Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14620595 | 0.85 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL11450683 | 0.82 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL757021 | 0.80 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL14620598 | 0.79 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL958454 | 0.79 | TSHR (0.50) | ALDH1A1SMN1; SMN2CYP1A2KMT2ANPC1 | |
| SCHEMBL14620099 | 0.78 | KMT2A (0.51) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL1561845 | 0.78 | HPSE (0.53) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL14620100 | 0.77 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL24437289 | 0.77 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A | |
| SCHEMBL10284047 | 0.76 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2026-05-21 | — | — | US | disclosed |
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | INSTITUT CURIE (FR) | 2026-01-20 | — | — | US | disclosed |
| US-20220233673-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2022-07-28 | — | — | US | disclosed |
| EP-1644426-B1 | POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO LTD (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-7157205-B2 | Intermediate layer composition for multilayer resist process, pattern-forming process using the same, and laminate | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7132213-B2 | Positive photoresist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2006-11-07 | — | — | US | disclosed |
| US-20060166131-A1 | Positive photoresist composition and method of forming resist pattern | TOKYO OHKA KOGYO, CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1644426-A1 | POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005007718-A1 | POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2005-01-27 | — | — | WO | disclosed |
| US-4242507-A | Sulfonic acid esters | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | STXBP1, RNGTT, UPF1 | ALDH1A1 4838/4885SMN1; SMN2 431/4885CYP1A2 4734/4885 |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | STXBP1, HBB, UPF1 | ALDH1A1 4710/4885SMN1; SMN2 526/4885CYP1A2 4748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.